|
PITPNB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.20259999969852E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.86409999999704E-05 |
| Normal-vs-Stage2 |
8.177000E-04 |
| Normal-vs-Stage3 |
1.37089999996398E-06 |
| Normal-vs-Stage4 |
1.33899999976705E-07 |
| Stage1-vs-Stage2 |
3.786000E-01 |
| Stage1-vs-Stage3 |
1.381780E-01 |
| Stage1-vs-Stage4 |
2.683900E-02 |
| Stage2-vs-Stage3 |
8.578000E-01 |
| Stage2-vs-Stage4 |
3.021800E-01 |
| Stage3-vs-Stage4 |
2.900200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.82920000047338E-07 |
| Normal-vs-AfricanAmerican |
9.221900E-03 |
| Normal-vs-Asian |
1.674980E-01 |
| Caucasian-vs-AfricanAmerican |
8.223000E-01 |
| Caucasian-vs-Asian |
3.192400E-02 |
| AfricanAmerican-vs-Asian |
1.303790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70805999999413E-05 |
| Normal-vs-Female |
1.34429999998353E-06 |
| Male-vs-Female |
6.868800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.961400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.85399999972103E-07 |
| Normal-vs-Age(61-80Yrs) |
6.65279999978452E-07 |
| Normal-vs-Age(81-100Yrs) |
6.523400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.589020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.571900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.194600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.698000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.342190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.055800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.114600E-01 |
| Classical-VS-Follicular |
1.042170E-02 |
| Classical-VS-Other |
9.681900E-02 |
| Classical-VS-Normal |
3.383400E-04 |
| Tall-VS-Follicular |
6.128200E-01 |
| Tall-VS-Other |
3.841200E-01 |
| Tall-VS-Normal |
6.814000E-04 |
| Follicular-VS-Other |
5.638800E-01 |
| Follicular-VS-Normal |
1.10689999999192E-06 |
| Other-VS-Normal |
5.449600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78419999996571E-07 |
| Normal-vs-N1 |
2.36859999999117E-05 |
| N0-vs-N1 |
6.919800E-01 |
|
|
